Bio21's Associate Professor Neil O’Brien-Simpson and Professor Eric Reynolds from the Faculty of Medicine, Dentistry and Health Sciences and Bio21 Institute were on the team that created the star-shaped ‘peptide polymer’ structures that hold promise for a new treatment methods against superbugs.
Bio21's Michael Parker is part of an international collaboration that has shown how the bacteria Gardnerella vaginalis targets cells and causes infection in women
The Honourable Frank McGuire, Jan Tennent, CEO of BioMedVic and Professor Ian Gust, former Head of CSL’s Research and Development division, in the Bio21 atrium.